Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $28.6M | $27.4M | $26.6M | $60M | $434.4M | |
| Revenue Growth (YoY) | 12293.07% | -4.44% | -2.84% | 125.73% | 624.06% | |
| Cost of Revenues | -- | $2.8M | $1M | $3.3M | $3M | |
| Gross Profit | -- | $24.6M | $25.5M | $56.7M | $431.5M | |
| Gross Profit Margin | -- | 89.86% | 96.12% | 94.48% | 99.32% | |
| R&D Expenses | $76M | $129.1M | $126.2M | $120.2M | $138.1M | |
| Selling, General & Admin | $18.6M | $27.2M | $31.7M | $33.5M | $43.5M | |
| Other Inc / (Exp) | -$631K | -$149K | -$80K | -$201K | $250K | |
| Operating Expenses | $66M | $153.5M | $156.9M | $150.3M | $178.6M | |
| Operating Income | -$66M | -$128.9M | -$131.4M | -$93.7M | $252.8M | |
| Net Interest Expenses | $598K | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$65.8M | -$128.7M | -$127.4M | -$79M | $279.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $305K | -$3.1M | -- | -- | $4.2M | |
| Net Income to Company | -$66.2M | -$125.6M | -$127.4M | -$79M | $275.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$66.2M | -$125.6M | -$127.4M | -$79M | $275.2M | |
| Basic EPS (Cont. Ops) | -$1.92 | -$2.71 | -$2.60 | -$1.39 | $4.47 | |
| Diluted EPS (Cont. Ops) | -$1.92 | -$2.71 | -$2.60 | -$1.39 | $4.23 | |
| Weighted Average Basic Share | $34.4M | $46.3M | $49M | $56.8M | $61.6M | |
| Weighted Average Diluted Share | $34.4M | $46.3M | $49M | $56.8M | $65.1M | |
| EBITDA | -$65.2M | -$126.2M | -$130.3M | -$90.3M | $255.8M | |
| EBIT | -$66M | -$128.9M | -$131.4M | -$93.7M | $252.8M | |
| Revenue (Reported) | $28.6M | $27.4M | $26.6M | $60M | $434.4M | |
| Operating Income (Reported) | -$66M | -$128.9M | -$131.4M | -$93.7M | $252.8M | |
| Operating Income (Adjusted) | -$66M | -$128.9M | -$131.4M | -$93.7M | $252.8M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $10.3M | -- | -- | $4.7M | $4.7M | |
| Revenue Growth (YoY) | -21.57% | -100% | -- | -- | 0.79% | |
| Cost of Revenues | -- | $853K | $827K | $647K | $361K | |
| Gross Profit | -- | -$853K | -$827K | $4M | $4.4M | |
| Gross Profit Margin | -- | -- | -- | 86.16% | 92.34% | |
| R&D Expenses | $37.5M | $25.4M | $30.7M | $36M | $40M | |
| Selling, General & Admin | $7.3M | $6.9M | $7.7M | $10.2M | $11.1M | |
| Other Inc / (Exp) | -- | -$86K | -$31K | $141K | -- | |
| Operating Expenses | $34.4M | $31.5M | $37.5M | $45.5M | $50.8M | |
| Operating Income | -$34.4M | -$32.3M | -$38.3M | -$41.5M | -$46.4M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$34.3M | -$31.2M | -$34.1M | -$33.6M | -$39.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$500K | -- | -- | -$420K | -- | |
| Net Income to Company | -$33.8M | -$31.2M | -$34.1M | -$33.2M | -$39.3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$33.8M | -$31.2M | -$34.1M | -$33.2M | -$39.3M | |
| Basic EPS (Cont. Ops) | -$0.70 | -$0.64 | -$0.58 | -$0.54 | -$0.62 | |
| Diluted EPS (Cont. Ops) | -$0.70 | -$0.64 | -$0.58 | -$0.54 | -$0.62 | |
| Weighted Average Basic Share | $48M | $49.1M | $59.2M | $61.8M | $63.8M | |
| Weighted Average Diluted Share | $48M | $49.1M | $59.2M | $61.8M | $63.8M | |
| EBITDA | -$33.7M | -$31.5M | -$37.5M | -$40.8M | -$46.1M | |
| EBIT | -$34.4M | -$32.3M | -$38.3M | -$41.5M | -$46.4M | |
| Revenue (Reported) | $10.3M | -- | -- | $4.7M | $4.7M | |
| Operating Income (Reported) | -$34.4M | -$32.3M | -$38.3M | -$41.5M | -$46.4M | |
| Operating Income (Adjusted) | -$34.4M | -$32.3M | -$38.3M | -$41.5M | -$46.4M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $24.4M | $35.2M | -- | $323.8M | $209.2M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | $3.3M | $2.7M | $3.2M | $1.5M | |
| Gross Profit | -- | $31.9M | -$2.7M | $320.6M | $207.7M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $109.6M | $135.6M | $121.1M | $132.1M | $147.8M | |
| Selling, General & Admin | $24.9M | $32.4M | $32.1M | $42.6M | $42.4M | |
| Other Inc / (Exp) | -$145K | -$164K | -$174K | $263K | -- | |
| Operating Expenses | $110.2M | $164.6M | $150.5M | $171.5M | $188.7M | |
| Operating Income | -$110.2M | -$132.8M | -$153.2M | $149.1M | $19M | |
| Net Interest Expenses | $127K | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$109.8M | -$131M | -$140.5M | $173.1M | $48.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$2.3M | -$900K | -- | $2.2M | $2.2M | |
| Net Income to Company | -$107.5M | -$130.1M | -$140.5M | $170.8M | $45.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$107.5M | -$130.1M | -$140.5M | $170.8M | $45.9M | |
| Basic EPS (Cont. Ops) | -$2.41 | -$2.67 | -$2.61 | $2.82 | $0.76 | |
| Diluted EPS (Cont. Ops) | -$2.41 | -$2.67 | -$2.61 | $2.67 | $0.63 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$108M | -$129.4M | -$150.5M | $152.3M | $20.5M | |
| EBIT | -$110.2M | -$132.8M | -$153.2M | $149.1M | $19M | |
| Revenue (Reported) | $24.4M | $35.2M | -- | $323.8M | $209.2M | |
| Operating Income (Reported) | -$110.2M | -$132.8M | -$153.2M | $149.1M | $19M | |
| Operating Income (Adjusted) | -$110.2M | -$132.8M | -$153.2M | $149.1M | $19M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $18.7M | $26.6M | -- | $263.8M | $38.6M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | $2.5M | $2.5M | $2.4M | $904K | |
| Gross Profit | -- | $24.1M | -$2.5M | $261.4M | $37.7M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $90.1M | $96.3M | $91.3M | $103.2M | $112.9M | |
| Selling, General & Admin | $19.9M | $25.1M | $25.4M | $34.5M | $33.4M | |
| Other Inc / (Exp) | -$136K | -$151K | -$245K | $219K | $118K | |
| Operating Expenses | $91.3M | $118.9M | $114.2M | $135.4M | $145.4M | |
| Operating Income | -$91.3M | -$94.9M | -$116.7M | $126.1M | -$107.8M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$90.9M | -$93.2M | -$106.3M | $145.7M | -$85.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$2.3M | -- | -- | $2.2M | $172K | |
| Net Income to Company | -$88.6M | -$93.2M | -$106.3M | $143.5M | -$85.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$88.6M | -$93.2M | -$106.3M | $143.5M | -$85.8M | |
| Basic EPS (Cont. Ops) | -$1.93 | -$1.90 | -$1.92 | $2.37 | -$1.35 | |
| Diluted EPS (Cont. Ops) | -$1.93 | -$1.90 | -$1.92 | $2.22 | -$1.35 | |
| Weighted Average Basic Share | $137.1M | $146.9M | $166.5M | $183.9M | $190.2M | |
| Weighted Average Diluted Share | $137.1M | $146.9M | $166.5M | $186.7M | $190.2M | |
| EBITDA | -$89.4M | -$92.3M | -$114.2M | $128.4M | -$106.9M | |
| EBIT | -$91.3M | -$94.9M | -$116.7M | $126.1M | -$107.8M | |
| Revenue (Reported) | $18.7M | $26.6M | -- | $263.8M | $38.6M | |
| Operating Income (Reported) | -$91.3M | -$94.9M | -$116.7M | $126.1M | -$107.8M | |
| Operating Income (Adjusted) | -$91.3M | -$94.9M | -$116.7M | $126.1M | -$107.8M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $305.8M | $326.9M | $237.4M | $341.6M | $418.9M | |
| Short Term Investments | $188.5M | $203.2M | $111.6M | $154.9M | $321.7M | |
| Accounts Receivable, Net | $2.4M | $1.6M | $10K | $10M | $165M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $6M | $8.5M | $5.7M | $3.6M | $4.2M | |
| Other Current Assets | $311K | -- | -- | -- | -- | |
| Total Current Assets | $315.6M | $340.7M | $243.1M | $355.6M | $591.6M | |
| Property Plant And Equipment | $6.4M | $6.7M | $4.6M | $2.1M | $12.6M | |
| Long-Term Investments | $2.5M | $225K | $225K | $225K | $140.5M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $450K | $225K | $225K | $225K | $225K | |
| Total Assets | $325.5M | $347.7M | $247.9M | $358.2M | $746.8M | |
| Accounts Payable | $5.8M | $2.5M | $3.7M | $775K | $1.6M | |
| Accrued Expenses | $12M | $30.2M | $19.6M | $12.5M | $12.5M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $1.5M | $2.2M | $2.5M | $1.1M | $510K | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $40.2M | $44M | $31.2M | $21.3M | $47.4M | |
| Long-Term Debt | $4.5M | $3.7M | $1.1M | -- | $10.4M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $45.9M | $47.7M | $32.3M | $21.5M | $71.5M | |
| Common Stock | -- | -- | -- | $1K | $1K | |
| Other Common Equity Adj | $28K | -$299K | -$359K | -$105K | -$82K | |
| Common Equity | $279.6M | $300M | $215.6M | $336.7M | $675.3M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $279.6M | $300M | $215.6M | $336.7M | $675.3M | |
| Total Liabilities and Equity | $325.5M | $347.7M | $247.9M | $358.2M | $746.8M | |
| Cash and Short Terms | $305.8M | $326.9M | $237.4M | $341.6M | $418.9M | |
| Total Debt | $4.5M | $3.7M | $1.1M | -- | $10.4M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $314.3M | $267.4M | $320.8M | $468.7M | $576.1M | |
| Short Term Investments | $193.8M | $114.6M | $90.2M | $337.6M | -- | |
| Accounts Receivable, Net | $2.6M | $125K | -- | -- | $583K | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | $8.6M | $4.1M | $5.4M | $5M | |
| Other Current Assets | $8.9M | -- | -- | -- | -- | |
| Total Current Assets | $327.7M | $276.6M | $324.9M | $476.8M | $586.4M | |
| Property Plant And Equipment | $7.1M | $5.3M | $2.9M | $12.3M | $12.3M | |
| Long-Term Investments | $38.4M | $225K | $2.2M | $114.8M | $103M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $225K | $225K | $225K | $225K | -- | |
| Total Assets | $373.2M | $282.2M | $330M | $603.9M | $701.7M | |
| Accounts Payable | $1.8M | $4.7M | $1.3M | $3M | $5.6M | |
| Accrued Expenses | $27.5M | $24.6M | $20.1M | $12.5M | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $2M | $2.4M | $1.8M | $45K | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $39.2M | $36.8M | $27.9M | $44.6M | $44.9M | |
| Long-Term Debt | $4.2M | $1.8M | -- | $10.9M | $8.5M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $43.5M | $38.6M | $27.9M | $71.9M | $56.3M | |
| Common Stock | -- | -- | $1K | $1K | $1K | |
| Other Common Equity Adj | -$204K | -$480K | -$170K | $1.3M | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $329.7M | $243.6M | $302.1M | $531.9M | $645.4M | |
| Total Liabilities and Equity | $373.2M | $282.2M | $330M | $603.9M | $701.7M | |
| Cash and Short Terms | $314.3M | $267.4M | $320.8M | $468.7M | $576.1M | |
| Total Debt | $4.2M | $1.8M | -- | $10.9M | $8.5M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$66.2M | -$125.6M | -$127.4M | -$79M | $275.2M | |
| Depreciation & Amoritzation | $789K | $2.8M | $1M | $3.3M | $2.9M | |
| Stock-Based Compensation | $7.9M | $16.4M | $24.2M | $29.3M | $37.6M | |
| Change in Accounts Receivable | $3.3M | -$915K | $4.2M | -$10M | -$155M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$72.5M | -$107.9M | -$108.1M | -$70.2M | $184.2M | |
| Capital Expenditures | $471K | $1.1M | $795K | $609K | $1.4M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$91M | -$15.9M | $91.5M | -$39.3M | -$299.5M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$10.5M | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$14K | -$189K | -$163K | -$769K | -$600K | |
| Cash From Financing | $247.6M | $129.9M | $18.8M | $170.5M | $25.9M | |
| Beginning Cash (CF) | $117.4M | $123.7M | $125.7M | $186.7M | $97.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $84.4M | $6.1M | $2.1M | $61M | -$89.5M | |
| Ending Cash (CF) | $201.9M | $129.6M | $127.7M | $247.7M | $7.8M | |
| Levered Free Cash Flow | -$73M | -$109M | -$108.9M | -$70.8M | $182.8M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$33.8M | -$31.2M | -$34.1M | -$33.2M | -$39.3M | |
| Depreciation & Amoritzation | $704K | $853K | $827K | $647K | $361K | |
| Stock-Based Compensation | $4.8M | $6M | $6.8M | $10.2M | $10.6M | |
| Change in Accounts Receivable | $5.3M | $2.6M | $39K | $43K | -$583K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$28.5M | -$25.2M | -$26.6M | -$27.9M | -$1.9M | |
| Capital Expenditures | $265K | $162K | $404K | $775K | $88K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$44.7M | $57.3M | -$13.6M | -$208.7M | -$58.6M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -$2K | -- | -- | -- | |
| Cash From Financing | $1.4M | $680K | $35.3M | $12.1M | $5.7M | |
| Beginning Cash (CF) | $120.5M | $152.8M | $230.5M | $131.1M | $113.7M | |
| Foreign Exchange Rate Adjustment | -$74K | -$175K | -- | -- | -- | |
| Additions / Reductions | -$71.9M | $32.6M | -$4.9M | -$224.5M | -$54.8M | |
| Ending Cash (CF) | $48.6M | $185.2M | $225.7M | -$93.4M | $58.9M | |
| Levered Free Cash Flow | -$28.7M | -$25.4M | -$27M | -$28.6M | -$2M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$107.5M | -$130.1M | -$140.5M | $170.8M | $45.9M | |
| Depreciation & Amoritzation | $813K | $3.3M | $985K | $3.2M | $1.4M | |
| Stock-Based Compensation | $13.3M | $23.7M | $28.2M | $35.1M | $44.4M | |
| Change in Accounts Receivable | -$1.2M | $4.3M | $92K | -- | -$583K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$99.8M | -$103.4M | -$118.8M | $230.3M | $65.5M | |
| Capital Expenditures | $1M | $921K | $660K | $1.1M | $1.8M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$118.1M | $115.4M | $26M | -$352M | -$106.9M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$189K | -$163K | -$769K | -$600K | -- | |
| Cash From Financing | $254.7M | $20.5M | $170.5M | $22.3M | $24.1M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $36.7M | $32.3M | $77.7M | -$99.4M | -$17.3M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$100.8M | -$104.4M | -$119.5M | $229.2M | $63.7M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$88.6M | -$93.2M | -$106.3M | $143.5M | -$85.8M | |
| Depreciation & Amoritzation | $2M | $2.5M | $2.5M | $2.4M | $904K | |
| Stock-Based Compensation | $11.4M | $18.7M | $22.7M | $28.5M | $35.3M | |
| Change in Accounts Receivable | -$1.1M | $4.2M | $10K | $10M | $164.4M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$80.9M | -$76.5M | -$87.2M | $213.3M | $94.6M | |
| Capital Expenditures | $905K | $725K | $590K | $1M | $1.4M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$43.7M | $87.5M | $22M | -$290.8M | -$98.1M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$189K | -$163K | -$769K | -$600K | -$479K | |
| Cash From Financing | $127.8M | $18.3M | $170M | $21.8M | $20M | |
| Beginning Cash (CF) | $396M | $371.5M | $593.6M | $659.3M | $421.9M | |
| Foreign Exchange Rate Adjustment | -$148K | -$165K | -- | -- | -- | |
| Additions / Reductions | $2.9M | $29.2M | $104.8M | -$55.6M | $16.5M | |
| Ending Cash (CF) | $398.8M | $400.5M | $698.4M | $603.7M | $438.4M | |
| Levered Free Cash Flow | -$81.8M | -$77.2M | -$87.8M | $212.3M | $93.2M | |
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.